CD274 and cancer: PD-L1 on the surface of cancer cells binds its receptor PD-1 to the surface of cytotoxic effector T cells such as CD8+ T cells to inhibit T-cell activation and promote T-cell exhaustion and death, resulting in the immune escape of these cancer cells [59].